News Archive - Page 40 of 118 - Life Sciences Scotland

Clear

Sanofi Exercises Option on Exscientia-Designed BiSpecific Small Molecule for Treatment of Immunological Conditions

AI Design enables new bispecific small molecule modality Exscientia, the world-leading Artificial Intelligence (AI)-driven drug discovery company, today announced that...

5th Aug 2019

3F BIO secures €17m backing from European Commission for first integrated bio-based protein biorefinery

Flagship grant awarded for first-of-its-kind zero-waste biorefinery to produce proteins for food from low-cost sustainable feedstocks 3F BIO, along with...

2nd Aug 2019

Radiotherapy targets tumours precisely – with less damage to healthy cells

A new way of concentrating radiotherapy dose in tumours, while minimising damage to healthy cells, has been proposed in research led by...

26th Jul 2019

Exscientia Enters Broad Rare Disease Drug Discovery Collaboration with Rallybio

Joint venture will initiate drug discovery programs targeting rare diseases using AI Exscientia, a world-leading Artificial Intelligence (AI)-driven drug discovery...

23rd Jul 2019

Professor Sara Linse presents new data on protein interactions in Alzheimer’s disease using the Fluidity One-W at FEBS 2019

Fluidic Analytics’ diffusional sizing technology has been influential in a recent study that investigates protein binding and self-assembly in Alzheimer’s...

11th Jul 2019

Biorefinery Roadmap for Scotland – Building a Sustainable Future launched in America this week

The Biorefinery Roadmap for Scotland – Building a Sustainable Future was launched by Roger Kilburn, CEO of IBioIC at BIO...

8th Jul 2019

Learn About Our Key Subsectors

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News